Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    alogliptin
Show Display Options
Rank Status Study
1 Completed
Has Results
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Alogliptin
2 Completed
Has Results
Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention: Drug: Alogliptin
3 Completed Alogliptin/Pioglitazone (Liovel) Liovel Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin/pioglitazone
4 Not yet recruiting Phase 3 Alogliptin Pediatric Study
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin Benzoate;   Drug: Placebo
5 Recruiting Local, Multicenter, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2
Condition: Diabetes Mellitus
Intervention: Drug: Alogliptin Benzoate
6 Completed
Has Results
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Conditions: Diabetes Mellitus, Type 2;   Acute Coronary Syndrome
Interventions: Drug: Alogliptin;   Drug: Placebo
7 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
8 Completed
Has Results
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Rapid-acting insulin secretagogue
9 Completed
Has Results
Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants
Condition: Pharmacokinetics and Pharmacodynamics
Intervention: Drug: Alogliptin
10 Recruiting An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Trelagliptin;   Drug: Alogliptin
11 Completed
Has Results
Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin and pioglitazone
12 Completed
Has Results
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Glipizide
13 Completed Study of Combination Therapy With SYR-322
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Insulin
14 Active, not recruiting Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
Condition: Surveillance
Intervention: Drug: Alogliptin
15 Completed
Has Results
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin and voglibose
16 Completed Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
Condition: Surveillance
Intervention: Drug: Alogliptin
17 Completed Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
Condition: Surveillance
Intervention: Drug: Alogliptin
18 Completed Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"
Condition: Patients With Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
Intervention: Drug: Alogliptin
19 Completed
Has Results
Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Placebo
20 Completed
Has Results
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Metformin;   Drug: Glipizide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.